Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 751-757

  Jones, Kevin B ^a,b   Schiffman, Joshua D ^a,b   Kohlmann, Wendy ^b   Randall, R Lor ^a,b   Lessnick, Stephen L ^a,b   Cannon Albright, Lisa A ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVEOLAR SOFT PARTS SARCOMA; AMELOBLASTOMA; ANGIOSARCOMA; ARTICLE; BRAIN CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHONDROSARCOMA; CHORDOMA; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; CONTROLLED STUDY; DESMOPLASTIC SMALL ROUND CELL TUMOR; EMBRYONAL RHABDOMYOSARCOMA; ENVIRONMENTAL FACTOR; EPITHELIOID SARCOMA; ESOPHAGUS CANCER; EWING SARCOMA; EXTRASKELETAL MYXOID CHONDROSARCOMA; FAMILIAL CANCER; FIBROMYXOSARCOMA; FIBROSARCOMA; GALLBLADDER CANCER; GENETIC RISK; GENOTYPE; HEREDITY; HIGH RISK PATIENT; HUMAN; INFANTILE FIBROSARCOMA; INHERITANCE; KARYOTYPE; KIDNEY CANCER; LEIOMYOSARCOMA; LIP CANCER; LIVER CANCER; LOW GRADE MYOFIBROBLASTIC SARCOMA; LUNG CANCER; LYMPHOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT MESENCHYMOMA; MYXOSARCOMA; OSTEOSARCOMA; OVARY CANCER; PEDIGREE ANALYSIS; PHARYNX CANCER; PHYLOGENY; PLEIOMORPHIC LIPOSARCOMA; PLEIOMORPHIC RHABDOMYOSARCOMA; PLEIOMORPHIC SARCOMA; PRIORITY JOURNAL; PROSTATE CANCER; RELATIVE; RHABDOMYOSARCOMA; RISK ASSESSMENT; ROUND CELL LIPOSARCOMA; SARCOMA; SYNOVIAL SARCOMA; TESTIS CANCER;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; MALE; MODELS, GENETIC; MODELS, STATISTICAL; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; RISK FACTORS; SARCOMA;

EID: 79955777890     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1174     Document Type: Article

References (44)

1. Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin North Am 2008;88:451-81, v.
2. Clarys JP, Martin AD, Marfell-Jones MJ, Janssens V, Caboor D, Drinkwater DT. Human body composition: a review of adult dissection data. Am J Hum Biol 1999;11:167-74. (Pubitemid 129726286)
3. Skolnick MH. The Utah Genealogical Database: a resource for genetic epidemiology.In: Cairns J, Lyon JL, Skolnick MH, editors. Banbury Report No. 4: Cancer Incidence in Defined Populations. New York: Cold Spring Harbor Laboratories; 1980. p. 285-97.
4. Fletcher CDM, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002.
5. Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res1988;48:5358-62.
6. Francois J. Retinoblastoma and osteogenic sarcoma. Ophthalmologica 1977;175:185-91.
7. Larizza L, Roversi G, Volpi L. Rothmund-Thomson syndrome. Orphanet J Rare Dis 2010;5:2.
8. Helton KJ, Fletcher BD, Kun LE, Jenkins JJ III, Pratt CB. Bone tumors other than osteosarcoma after retinoblastoma. Cancer 1993;71:2847-53. (Pubitemid 23120067)
9. Mittal R, Al Awadi S, Sahar O, Behbehani AM. Ewing's sarcoma as second malignant neoplasm after retinoblastoma: a case report. Med Princ Pract 2008;17:84-5.
10. Ji J, Hemminki K. Familial risk for histology-specific bone cancers: an updated study in Sweden. Eur J Cancer 2006;42:2343-9. (Pubitemid 44307613)
11. Hutter RV, Francis KC, Foote FW Jr. Ewing's sarcoma in siblings: report of the second known occurrence. Am J Surg 1964;107:598-603.
12. Joyce MJ, Harmon DC, Mankin HJ, Suit HD, Schiller AL, Truman JT. Ewing's sarcoma in female siblings. A clinical report and review of the literature. Cancer 1984;53:1959-62.
13. Zamora P, Garcia de Paredes ML, Gonzalez Baron M, Diaz MA, Escobar Y, Ordóñez A, et al. Ewing's tumor in brothers. An unusual observation. Am J Clin Oncol 1986;9:358-60.
14. Ferris ITJ, Berbel Tornero O, Ortega Garcia JA, Claudio-Morales L, García I Castell J, Martí Perales V, et al. [Risk factors for pediatric malignant bone tumors]. An Pediatr (Barc)2005;63:537-47.
15. Valery PC, Holly EA, Sleigh AC, Williams G, Kreiger N, Bain C. Hernias and Ewing's sarcoma family of tumours: a pooled analysis and meta-analysis. Lancet Oncol. 2005;6:485-90. (Pubitemid 40903629)
16. Valery PC, McWhirter W, Sleigh A, Williams G, Bain C. A national case-control study of Ewing's sarcoma family of tumours in Australia. Int J Cancer 2003;105:825-30. (Pubitemid 36706107)
17. Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence- related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer 2009;115:3526-36.
18. Randall RL, Lessnick SL, Jones KB, Gouw LG, Cummings JE, Cannon- Albright L, et al. Is there a predisposition gene for Ewing's sarcoma?J Oncol 2010;2010:397632.
19. Ghule P, Kadam PA, Jambhekar N, Bamne M, Pai S, Nair C, et al. p53 gene gets altered by various mechanisms: studies in childhood sarcomas and retinoblastoma. Med Sci Monit 2006;12:BR385-96.
20. Skolnick MH. Prospects for population oncogenetics. In:Mulvihill JJ, Miller RW, Fraumeni JF, editors. Genetics of Human Cancer. New York: Raven Press; 1977. p. 19-25.
21. Bishop DT, Skolnick MH. Genetic epidemiology of cancer in Utah genealogies: a prelude to the molecular genetics of common cancers. J Cell Physiol Suppl 1984;3:63-77. (Pubitemid 14099974)
22. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, et al. Familiality of cancer in Utah. Cancer Res 1994;54:2378-85. (Pubitemid 24138728)
23. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8. (Pubitemid 24336346)
24. Malecot G. Les Mathematiques de l'Heredite. Paris, France: Masson et Cie; 1948.
25. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH. Familial associations between cancer sites. Comput Biomed Res 1999;32:517-29. (Pubitemid 30013664)
26. Albright LA, Schwab A, Camp NJ, Farnham JS, Thomas A. Population- based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases. Prostate 2005;64:347-55. (Pubitemid 41193247)
27. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA. Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer 2005;117:655-61. (Pubitemid 41504555)
28. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-57. (Pubitemid 14030098)
29. Jorde LB. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 1989;53:339-55. (Pubitemid 19282107)
30. Hill JR. A survey of cancer sites by kinship in the Utah Mormon population. In:Cairns J, Lyon JL, Skolnick M, editors. Banbury Report No. 4: Cancer Incidence in Defined Populations. New York: Cold Spring Harbor Laboratories; 1980. p. 299-318.
31. Stefansson H, Geirsson RT, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002;17:555-9. (Pubitemid 34232419)
32. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008;197:18-24. (Pubitemid 351263461)
33. Cannon Albright LA. Utah family-based analysis: past, present and future. Hum Hered 2008;65:209-20. (Pubitemid 351172093)
34. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG. A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 2003;99:637-43. (Pubitemid 37159039)
35. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA. Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 2006;152:305-11. (Pubitemid 44109831)
36. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA. Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation 9 2004;110:3143-8. (Pubitemid 39492011)
37. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009;123:124-33.
38. Ginsberg JP, Goodman P, Leisenring W, Ness KK, Meyers PA, Wolden SL, et al. Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst 2010;102:1272-83.
39. MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990;9:125-36. (Pubitemid 20311829)
40. Biggar RJ, Horm J, Goedert JJ, Melbye M. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol 1987;126:578-86.
41. Hoar SK, Blair A, Holmes FF, Boysen CD, Robel RJ, Hoover R, et al. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA 1986;256:1141-7. (Pubitemid 16054977)
42. Buehler SK, Firme F, Fodor G, Fraser GR, Marshall WH, Vaze P. Common variable immunodeficiency, Hodgkin's disease, and other malignancies in a Newfoundland family. Lancet 1975;1:195-7.
43. Meisner LF, Gilbert E, Ris HW, Haverty G. Genetic mechanisms in cancer predisposition: report of a cancer family. Cancer 1979;43:679-89. (Pubitemid 9122296)
44. Pastore G, Mosso ML, Carli M, Ghibaudo P, De Bernardi B, Mancini A, et al. Cancer mortality among relatives of children with soft-tissue sarcoma: a national survey in Italy. Cancer Lett 1987;37:17-24. (Pubitemid 17149417)